At that time, the company announced that ivonescimab had beaten the results of Merck’s anti-cancer drug, Keytruda. Summit’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback